Scpharmaceuticals Stock Market Value
| SCPH Stock | USD 3.46 0.10 2.98% |
| Symbol | Scpharmaceuticals |
Scpharmaceuticals Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.95) | Revenue Per Share 0.741 | Quarterly Revenue Growth 1.641 | Return On Assets (0.42) | Return On Equity (1.67) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Scpharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Scpharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Scpharmaceuticals.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Scpharmaceuticals on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Scpharmaceuticals or generate 0.0% return on investment in Scpharmaceuticals over 30 days. Scpharmaceuticals is related to or competes with Lyra Therapeutics, Hookipa Pharma, SAB Biotherapeutics, Cadrenal Therapeutics,, Monopar Therapeutics, Spero Therapeutics, and Coherus BioSciences. scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceut... More
Scpharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Scpharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Scpharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.20) | |||
| Maximum Drawdown | 20.7 | |||
| Value At Risk | (7.09) | |||
| Potential Upside | 4.3 |
Scpharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Scpharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Scpharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Scpharmaceuticals historical prices to predict the future Scpharmaceuticals' volatility.| Risk Adjusted Performance | (0.12) | |||
| Jensen Alpha | (0.81) | |||
| Total Risk Alpha | (1.09) | |||
| Treynor Ratio | (0.31) |
Scpharmaceuticals Backtested Returns
Scpharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.16, which indicates the firm had a -0.16% return per unit of risk over the last 3 months. Scpharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Scpharmaceuticals' Variance of 13.13, coefficient of variation of (601.01), and Risk Adjusted Performance of (0.12) to confirm the risk estimate we provide. The entity has a beta of 2.0, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Scpharmaceuticals will likely underperform. At this point, Scpharmaceuticals has a negative expected return of -0.57%. Please make sure to validate Scpharmaceuticals' skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Scpharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.25 |
Poor predictability
Scpharmaceuticals has poor predictability. Overlapping area represents the amount of predictability between Scpharmaceuticals time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Scpharmaceuticals price movement. The serial correlation of 0.25 indicates that over 25.0% of current Scpharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.25 | |
| Spearman Rank Test | 0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 0.13 |
Scpharmaceuticals lagged returns against current returns
Autocorrelation, which is Scpharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Scpharmaceuticals' stock expected returns. We can calculate the autocorrelation of Scpharmaceuticals returns to help us make a trade decision. For example, suppose you find that Scpharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Scpharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Scpharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Scpharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Scpharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Scpharmaceuticals Lagged Returns
When evaluating Scpharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Scpharmaceuticals stock have on its future price. Scpharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Scpharmaceuticals autocorrelation shows the relationship between Scpharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Scpharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Scpharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Scpharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Scpharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Scpharmaceuticals Stock:Check out Scpharmaceuticals Correlation, Scpharmaceuticals Volatility and Scpharmaceuticals Alpha and Beta module to complement your research on Scpharmaceuticals. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Scpharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.